Subjecting meta-analyses to closer scrutiny: Little support for differential efficacy among second-generation antipsychotics at equivalent doses. - Suppr | 超能文献

Subjecting meta-analyses to closer scrutiny: Little support for differential efficacy among second-generation antipsychotics at equivalent doses.

作者信息

Tandon Rajiv, Nasrallah Henry A

出版信息

Arch Gen Psychiatry. 2006 Aug;63(8):935-7; author reply 937-9. doi: 10.1001/archpsyc.63.8.935.

DOI:10.1001/archpsyc.63.8.935

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Subjecting meta-analyses to closer scrutiny: Little support for differential efficacy among second-generation antipsychotics at equivalent doses.

Arch Gen Psychiatry. 2006 Aug;63(8):935-7; author reply 937-9. doi: 10.1001/archpsyc.63.8.935.

2

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.第二代抗精神病药物治疗难治性精神分裂症患者的有效性：随机试验的综述与荟萃分析

Am J Psychiatry. 2001 Apr;158(4):518-26. doi: 10.1176/appi.ajp.158.4.518.

3

Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.为何奥氮平优于利培酮，利培酮优于喹硫平，而喹硫平又优于奥氮平：第二代抗精神病药物头对头比较研究的探索性分析

Am J Psychiatry. 2006 Feb;163(2):185-94. doi: 10.1176/appi.ajp.163.2.185.

4

The CATIE study.CATIE研究。

Am J Psychiatry. 2006 Mar;163(3):554-5; author reply 555-6. doi: 10.1176/appi.ajp.163.3.554.

5

New generation versus conventional antipsychotics.新一代抗精神病药物与传统抗精神病药物

Lancet. 2003 Aug 2;362(9381):404; author reply 404-5. doi: 10.1016/S0140-6736(03)14035-4.

6

Methodological concerns in a trial of ziprasidone and olanzapine.齐拉西酮与奥氮平试验中的方法学问题。

Am J Psychiatry. 2005 Jul;162(7):1391; author reply 1391-2. doi: 10.1176/appi.ajp.162.7.1391.

7

Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.精神分裂症随机非典型抗精神病药物试验中的对照组偏倚。

Arch Gen Psychiatry. 2005 Sep;62(9):961-70. doi: 10.1001/archpsyc.62.9.961.

8

[Short-term efficacy and safety of lurasidone in the treatment of schizophrenia].鲁拉西酮治疗精神分裂症的短期疗效与安全性

Encephale. 2014 Dec;40(6):507-17. doi: 10.1016/j.encep.2014.10.009.

9

Pretrial medication bias in randomized antipsychotic drug trials.随机抗精神病药物试验中的审前用药偏倚。

Am J Psychiatry. 2007 Aug;164(8):1266; author reply 1266-7. doi: 10.1176/appi.ajp.2007.07030404.

10

Comparing symptom response among antipsychotic medications in CATIE.比较CATIE研究中抗精神病药物之间的症状反应。

J Clin Psychopharmacol. 2013 Feb;33(1):123-6. doi: 10.1097/01.jcp.0000426178.43831.ed.

引用本文的文献

1

Relationship between obesity and antipsychotic drug use in the adult population: a longitudinal, retrospective claim database study in Primary Care settings.成年人肥胖与抗精神病药物使用的关系：初级保健环境中纵向、回顾性索赔数据库研究。

Neuropsychiatr Dis Treat. 2008 Feb;4(1):219-26. doi: 10.2147/ndt.s2139.